ask="1.4100"
ask_size="1100"
average_daily_volume="63427"
bid="1.3000"
bid_size="3000"
book_value="0.6940"
change="+0.0533"
change_from_200_day_moving_average="-0.1292"
change_from_50_day_moving_average="0.2589"
change_from_52_week_high="-6.5767"
change_From_52_week_low="0.4531"
change_in_percent="+4.0379%"
close="1.3733"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.1560"
ebitda="-17.60M"
eps_estimate_current_year="-1.0900"
eps_estimate_next_quarter="-0.2900"
eps_estimate_next_year="-0.8200"
ex_dividend_date="N/A"
float_shares="6119000"
high="1.4300"
high_52_weeks="7.9500"
last_trade_date="1/27/2017"
last_trade_price="1.3733"
last_trade_size="500"
last_trade_time="3:58pm"
low="1.3200"
low_52_weeks="0.9202"
market_capitalization="22.51M"
moving_average_200_day="1.5025"
moving_average_50_day="1.1144"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.0000"
open="1.3200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-8.6014%"
percent_change_from_50_day_moving_average="+23.2300%"
percent_change_from_52_week_high="-82.7258%"
percent_change_from_52_week_low="+49.2393%"
previous_close="1.3200"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.9020"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.6100"
stock_exchange="NGM"
symbol="ORPN"
volume="179523"
weeks_range_52="0.9202 - 7.9500"
